A Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Forecasts to 2032 – Global Analysis By Dosage Form (Solid Dosage Form Automation, Liquid Dosage Form Automation, and Semisolid Dosage Form Automation), Packaging Type, Technology
Description
According to Stratistics MRC, the Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market is accounted for $7.0 billion in 2025 and is expected to reach $15.0 billion by 2032 growing at a CAGR of 11.5% during the forecast period. Automation in pharmaceutical manufacturing involves using control systems to operate equipment for producing solid (tablets, capsules) and liquid (syrups, injections) dosage forms with minimal human intervention. It encompasses processes like dispensing, mixing, granulation, compression, filling, and packaging. This enhances precision, efficiency, and compliance with stringent regulations. By ensuring consistent product quality, reducing contamination risks, and improving batch traceability, automation is vital for scaling up production and maintaining Good Manufacturing Practice (GMP).
According to Springer’s Therapeutic Innovation & Regulatory Science journal, artificial intelligence is transforming liquid dosage formulation by enabling data-driven optimization. AI improves efficiency in drug discovery, formulation, and manufacturing, reducing reliance on trial-and-error methods
Market Dynamics:
Driver:
Rising demand for production efficiency
The increasing focus on improving production efficiency is propelling automation adoption in solid and liquid dosage pharmaceutical manufacturing. Fueled by the growing need to minimize manual intervention, enhance precision, and optimize throughput, manufacturers are investing in advanced automated systems. Automation solutions streamline operations, reduce cycle times, and ensure consistent quality, particularly in complex dosage formulations. Moreover, the integration of robotics and AI-driven control systems enhances process reliability, ensuring compliance with regulatory standards and scalability in pharmaceutical output.
Restraint:
High initial capital investment
Despite its benefits, high upfront investment acts as a key barrier to widespread automation deployment in pharmaceutical dosage manufacturing. The integration of robotics, vision inspection, and digital monitoring technologies requires significant capital, particularly for small and mid-sized firms. Additionally, customization and validation costs further elevate financial burdens. Spurred by stringent compliance requirements and maintenance complexities, many firms delay automation adoption. Consequently, the return on investment period extends, limiting faster technological penetration across developing pharmaceutical production environments.
Opportunity:
Growth in personalized medicine packaging
The emergence of personalized medicine is unlocking lucrative automation opportunities in pharmaceutical manufacturing. As customized dosage forms and patient-specific therapies gain traction, automated packaging and dosing systems ensure precision and flexibility. Advanced robotics and adaptive control technologies enable batch-level customization and real-time adjustments. Driven by the demand for individual-centric drug delivery, automation helps reduce errors, enhance traceability, and streamline small-batch production. Consequently, pharmaceutical players are adopting digital automation to support the scalability of personalized and precision-based drug packaging processes.
Threat:
Supply chain disruptions impact automation
Global supply chain disruptions pose a substantial threat to automation-driven pharmaceutical manufacturing. Interruptions in semiconductor availability, equipment logistics, and component shortages hinder system integration and commissioning. Moreover, dependency on specialized vendors for automation components amplifies vulnerability during geopolitical tensions. Spurred by fluctuating material costs and delayed installations, production continuity risks rise. Hence, companies increasingly focus on regionalized sourcing strategies and resilient supplier networks to mitigate automation downtime and maintain operational reliability in dosage manufacturing lines.
Covid-19 Impact:
The COVID-19 pandemic accelerated automation adoption across solid and liquid dosage manufacturing due to heightened demand for uninterrupted production. Fueled by labor shortages and social distancing norms, companies turned to robotic handling and automated inspection systems. Additionally, remote monitoring and digital twin technologies supported predictive maintenance and quality control. However, initial lockdowns delayed equipment procurement and installation. Over time, the crisis reinforced the strategic necessity for automation, transforming production agility and reinforcing resilience across pharmaceutical manufacturing workflows.
The solid dosage form automation segment is expected to be the largest during the forecast period
The solid dosage form automation segment is expected to account for the largest market share during the forecast period, propelled by its extensive application in tablet compression, coating, and packaging operations. Manufacturers are emphasizing precision and repeatability in large-scale tablet production, driving automation uptake. Fueled by demand for consistency and compliance, automated systems enhance throughput and quality control. Additionally, the segment benefits from increasing investments in robotic dispensing, automated filling, and inspection units that reduce operational variability.
The primary packaging automation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the primary packaging automation segment is predicted to witness the highest growth rate, influenced by rising requirements for product safety and contamination prevention. Driven by stringent regulatory mandates, automated primary packaging systems enhance sealing precision and minimize human contact. Furthermore, the growing shift toward blister, sachet, and vial packaging for both solid and liquid dosage forms accelerates adoption. Integration of machine vision and AI ensures labeling accuracy and traceability, boosting this segment’s expansion trajectory.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by rapid pharmaceutical manufacturing expansion in China, India, and South Korea. Government incentives supporting industrial automation and investments in advanced production facilities bolster growth. Additionally, rising generics output and contract manufacturing activities enhance automation integration. The region’s growing pool of skilled engineers and cost-effective deployment environments further strengthen its leadership in automated solid and liquid dosage manufacturing adoption.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong digital transformation initiatives and early technology adoption among major pharmaceutical firms. The region’s established regulatory framework encourages process validation through automation. Additionally, increasing investments in smart factories and data-driven manufacturing enhance production agility. Fueled by a growing focus on personalized medicine and stringent FDA compliance, automation uptake continues to surge across U.S. and Canadian dosage production facilities.
Key players in the market
Some of the key players in Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market include Siemens, Rockwell Automation, Bosch Packaging, Syntegon, Körber Pharma, Becton Dickinson, IMA Group, Marchesini, OPTIMA Packaging, Uhlmann Pac-Systeme, Omnicell, ARxIUM, Yuyama Co., Ltd., Mitsubishi Electric, Honeywell, GEA Group, Thermo Fisher, and Schneider Electric.
Key Developments:
In September 2025, Siemens and Merck extended their strategic partnership to accelerate digital transformation in pharmaceutical manufacturing. The collaboration aims to integrate Merck’s SaaS products with Siemens’ digital ecosystem, deploying AI tools for smarter, faster drug development using technology from Siemens’ July 2025 Dotmatics acquisition.
In October 2025, Rockwell Automation launched the ControlLogix 5590 Controller, a next-generation platform designed for advanced industrial and pharmaceutical automation, featuring integrated safety and multidiscipline control for streamlined manufacturing.
In May 2025, Syntegon premiered its SynTiso line for automated liquid pharmaceutical filling, developed in direct collaboration with two major pharmaceutical partners, to enhance automation and yield while reducing operator intervention.
Dosage Forms Covered:
• Solid Dosage Form Automation
• Liquid Dosage Form Automation
• Semisolid Dosage Form Automation
Packaging Types Covered:
• Primary Packaging Automation
• Secondary Packaging Automation
• Tertiary Packaging Automation
Technologies Covered:
• Robotics & Pick-and-Place Systems
• Vision Inspection Systems
• Labeling & Serialization Systems
• Conveyors & Automated Material Handling
• Blow-Fill-Seal (BFS) Technology
• Form-Fill-Seal (FFS) Systems
Applications Covered:
• Drug Discovery & Development
• Clinical Trial Material Manufacturing
• Commercial Production &Processing
• Quality Control & Regulatory Compliance
• Logistics & Inventory Management
End Users Covered:
• Pharmaceutical Manufacturing Companies
• Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs/CMOs)
• Research and Academic Institutions
• Packaging & Equipment Manufacturers
Regions Covered:
• North AmericaUSCanadaMexico
• EuropeGermanyUKItalyFranceSpainRest of Europe
• Asia PacificJapan China India Australia New ZealandSouth KoreaRest of Asia Pacific
• South AmericaArgentinaBrazilChileRest of South America
• Middle East & Africa Saudi ArabiaUAEQatarSouth AfricaRest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
According to Springer’s Therapeutic Innovation & Regulatory Science journal, artificial intelligence is transforming liquid dosage formulation by enabling data-driven optimization. AI improves efficiency in drug discovery, formulation, and manufacturing, reducing reliance on trial-and-error methods
Market Dynamics:
Driver:
Rising demand for production efficiency
The increasing focus on improving production efficiency is propelling automation adoption in solid and liquid dosage pharmaceutical manufacturing. Fueled by the growing need to minimize manual intervention, enhance precision, and optimize throughput, manufacturers are investing in advanced automated systems. Automation solutions streamline operations, reduce cycle times, and ensure consistent quality, particularly in complex dosage formulations. Moreover, the integration of robotics and AI-driven control systems enhances process reliability, ensuring compliance with regulatory standards and scalability in pharmaceutical output.
Restraint:
High initial capital investment
Despite its benefits, high upfront investment acts as a key barrier to widespread automation deployment in pharmaceutical dosage manufacturing. The integration of robotics, vision inspection, and digital monitoring technologies requires significant capital, particularly for small and mid-sized firms. Additionally, customization and validation costs further elevate financial burdens. Spurred by stringent compliance requirements and maintenance complexities, many firms delay automation adoption. Consequently, the return on investment period extends, limiting faster technological penetration across developing pharmaceutical production environments.
Opportunity:
Growth in personalized medicine packaging
The emergence of personalized medicine is unlocking lucrative automation opportunities in pharmaceutical manufacturing. As customized dosage forms and patient-specific therapies gain traction, automated packaging and dosing systems ensure precision and flexibility. Advanced robotics and adaptive control technologies enable batch-level customization and real-time adjustments. Driven by the demand for individual-centric drug delivery, automation helps reduce errors, enhance traceability, and streamline small-batch production. Consequently, pharmaceutical players are adopting digital automation to support the scalability of personalized and precision-based drug packaging processes.
Threat:
Supply chain disruptions impact automation
Global supply chain disruptions pose a substantial threat to automation-driven pharmaceutical manufacturing. Interruptions in semiconductor availability, equipment logistics, and component shortages hinder system integration and commissioning. Moreover, dependency on specialized vendors for automation components amplifies vulnerability during geopolitical tensions. Spurred by fluctuating material costs and delayed installations, production continuity risks rise. Hence, companies increasingly focus on regionalized sourcing strategies and resilient supplier networks to mitigate automation downtime and maintain operational reliability in dosage manufacturing lines.
Covid-19 Impact:
The COVID-19 pandemic accelerated automation adoption across solid and liquid dosage manufacturing due to heightened demand for uninterrupted production. Fueled by labor shortages and social distancing norms, companies turned to robotic handling and automated inspection systems. Additionally, remote monitoring and digital twin technologies supported predictive maintenance and quality control. However, initial lockdowns delayed equipment procurement and installation. Over time, the crisis reinforced the strategic necessity for automation, transforming production agility and reinforcing resilience across pharmaceutical manufacturing workflows.
The solid dosage form automation segment is expected to be the largest during the forecast period
The solid dosage form automation segment is expected to account for the largest market share during the forecast period, propelled by its extensive application in tablet compression, coating, and packaging operations. Manufacturers are emphasizing precision and repeatability in large-scale tablet production, driving automation uptake. Fueled by demand for consistency and compliance, automated systems enhance throughput and quality control. Additionally, the segment benefits from increasing investments in robotic dispensing, automated filling, and inspection units that reduce operational variability.
The primary packaging automation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the primary packaging automation segment is predicted to witness the highest growth rate, influenced by rising requirements for product safety and contamination prevention. Driven by stringent regulatory mandates, automated primary packaging systems enhance sealing precision and minimize human contact. Furthermore, the growing shift toward blister, sachet, and vial packaging for both solid and liquid dosage forms accelerates adoption. Integration of machine vision and AI ensures labeling accuracy and traceability, boosting this segment’s expansion trajectory.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by rapid pharmaceutical manufacturing expansion in China, India, and South Korea. Government incentives supporting industrial automation and investments in advanced production facilities bolster growth. Additionally, rising generics output and contract manufacturing activities enhance automation integration. The region’s growing pool of skilled engineers and cost-effective deployment environments further strengthen its leadership in automated solid and liquid dosage manufacturing adoption.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong digital transformation initiatives and early technology adoption among major pharmaceutical firms. The region’s established regulatory framework encourages process validation through automation. Additionally, increasing investments in smart factories and data-driven manufacturing enhance production agility. Fueled by a growing focus on personalized medicine and stringent FDA compliance, automation uptake continues to surge across U.S. and Canadian dosage production facilities.
Key players in the market
Some of the key players in Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market include Siemens, Rockwell Automation, Bosch Packaging, Syntegon, Körber Pharma, Becton Dickinson, IMA Group, Marchesini, OPTIMA Packaging, Uhlmann Pac-Systeme, Omnicell, ARxIUM, Yuyama Co., Ltd., Mitsubishi Electric, Honeywell, GEA Group, Thermo Fisher, and Schneider Electric.
Key Developments:
In September 2025, Siemens and Merck extended their strategic partnership to accelerate digital transformation in pharmaceutical manufacturing. The collaboration aims to integrate Merck’s SaaS products with Siemens’ digital ecosystem, deploying AI tools for smarter, faster drug development using technology from Siemens’ July 2025 Dotmatics acquisition.
In October 2025, Rockwell Automation launched the ControlLogix 5590 Controller, a next-generation platform designed for advanced industrial and pharmaceutical automation, featuring integrated safety and multidiscipline control for streamlined manufacturing.
In May 2025, Syntegon premiered its SynTiso line for automated liquid pharmaceutical filling, developed in direct collaboration with two major pharmaceutical partners, to enhance automation and yield while reducing operator intervention.
Dosage Forms Covered:
• Solid Dosage Form Automation
• Liquid Dosage Form Automation
• Semisolid Dosage Form Automation
Packaging Types Covered:
• Primary Packaging Automation
• Secondary Packaging Automation
• Tertiary Packaging Automation
Technologies Covered:
• Robotics & Pick-and-Place Systems
• Vision Inspection Systems
• Labeling & Serialization Systems
• Conveyors & Automated Material Handling
• Blow-Fill-Seal (BFS) Technology
• Form-Fill-Seal (FFS) Systems
Applications Covered:
• Drug Discovery & Development
• Clinical Trial Material Manufacturing
• Commercial Production &Processing
• Quality Control & Regulatory Compliance
• Logistics & Inventory Management
End Users Covered:
• Pharmaceutical Manufacturing Companies
• Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs/CMOs)
• Research and Academic Institutions
• Packaging & Equipment Manufacturers
Regions Covered:
• North AmericaUSCanadaMexico
• EuropeGermanyUKItalyFranceSpainRest of Europe
• Asia PacificJapan China India Australia New ZealandSouth KoreaRest of Asia Pacific
• South AmericaArgentinaBrazilChileRest of South America
• Middle East & Africa Saudi ArabiaUAEQatarSouth AfricaRest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Table of Contents
200 Pages
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Dosage Form
- 5.1 Introduction
- 5.2 Solid Dosage Form Automation
- 5.2.1 Tablet Manufacturing
- 5.2.2 Capsule Filling & Sealing Systems
- 5.2.3 Granulation, Blending & Compression Control
- 5.3 Liquid Dosage Form Automation
- 5.3.1 Syrup & Suspension Production
- 5.3.2 Aseptic Filling & Sterilization Systems
- 5.3.3 Liquid Mixing & Homogenization
- 5.4 Semisolid Dosage Form Automation
- 5.4.1 Ointment & Cream Manufacturing
- 5.4.2 Gel & Paste Mixing Systems
- 5.4.3 Tube Filling & Sealing
- 6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Packaging Type
- 6.1 Introduction
- 6.2 Primary Packaging Automation
- 6.2.1 Blister Packaging Machines
- 6.2.2 Bottle Filling & Capping Systems
- 6.2.3 Strip Packaging Equipment
- 6.2.4 Vial and Ampoule Packaging
- 6.2.5 Sachet and Pouch Filling Systems
- 6.3 Secondary Packaging Automation
- 6.3.1 Cartoning & Case Packing Systems
- 6.3.2 Bundling, Wrapping, & Shrink Packaging
- 6.3.3 Serialization & Aggregation Systems
- 6.3.4 Palletizing, Depalletizing, & Labeling Robots
- 6.4 Tertiary Packaging Automation
- 6.4.1 Automated Guided Vehicles (AGVs) for Warehouse Handling
- 6.4.2 Bulk Handling and Shipping Container Systems
- 7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Technology
- 7.1 Introduction
- 7.2 Robotics & Pick-and-Place Systems
- 7.3 Vision Inspection Systems
- 7.4 Labeling & Serialization Systems
- 7.5 Conveyors & Automated Material Handling
- 7.6 Blow-Fill-Seal (BFS) Technology
- 7.7 Form-Fill-Seal (FFS) Systems
- 8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Application
- 8.1 Introduction
- 8.2 Drug Discovery & Development
- 8.3 Clinical Trial Material Manufacturing
- 8.4 Commercial Production &Processing
- 8.4.1 Active Pharmaceutical Ingredient (API) Manufacturing
- 8.4.2 Formulation and Compounding
- 8.5 Quality Control & Regulatory Compliance
- 8.6 Logistics & Inventory Management
- 9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By End User
- 9.1 Introduction
- 9.2 Pharmaceutical Manufacturing Companies
- 9.3 Biotechnology Companies
- 9.4 Contract Development & Manufacturing Organizations (CDMOs/CMOs)
- 9.5 Research and Academic Institutions
- 9.6 Packaging & Equipment Manufacturers
- 10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market, By Geography
- 10.1 Introduction
- 10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
- 10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
- 10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa
- 11 Key Developments
- 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 11.2 Acquisitions & Mergers
- 11.3 New Product Launch
- 11.4 Expansions
- 11.5 Other Key Strategies
- 12 Company Profiling
- 12.1 Siemens Healthineers
- 12.2 Rockwell Automation
- 12.3 Bosch Packaging Technology
- 12.4 Syntegon Technology
- 12.5 Körber Pharma
- 12.6 Becton Dickinson (BD)
- 12.7 IMA Group
- 12.8 Marchesini Group
- 12.9 OPTIMA Packaging Group
- 12.10 Uhlmann Pac-Systeme
- 12.11 Omnicell Inc.
- 12.12 ARxIUM
- 12.13 Yuyama Co., Ltd.
- 12.14 Mitsubishi Electric
- 12.15 Honeywell Process Solutions
- 12.16 GEA Group
- 12.17 Thermo Fisher Scientific
- 12.18 Schneider Electric
- List of Tables
- Table 1 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Dosage Form (2024-2032) ($MN)
- Table 3 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Solid Dosage Form Automation (2024-2032) ($MN)
- Table 4 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tablet Manufacturing (2024-2032) ($MN)
- Table 5 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Capsule Filling & Sealing Systems (2024-2032) ($MN)
- Table 6 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Granulation, Blending & Compression Control (2024-2032) ($MN)
- Table 7 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Dosage Form Automation (2024-2032) ($MN)
- Table 8 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Syrup & Suspension Production (2024-2032) ($MN)
- Table 9 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Aseptic Filling & Sterilization Systems (2024-2032) ($MN)
- Table 10 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Liquid Mixing & Homogenization (2024-2032) ($MN)
- Table 11 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Semisolid Dosage Form Automation (2024-2032) ($MN)
- Table 12 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Ointment & Cream Manufacturing (2024-2032) ($MN)
- Table 13 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Gel & Paste Mixing Systems (2024-2032) ($MN)
- Table 14 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tube Filling & Sealing (2024-2032) ($MN)
- Table 15 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging Type (2024-2032) ($MN)
- Table 16 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Primary Packaging Automation (2024-2032) ($MN)
- Table 17 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blister Packaging Machines (2024-2032) ($MN)
- Table 18 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bottle Filling & Capping Systems (2024-2032) ($MN)
- Table 19 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Strip Packaging Equipment (2024-2032) ($MN)
- Table 20 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vial and Ampoule Packaging (2024-2032) ($MN)
- Table 21 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Sachet and Pouch Filling Systems (2024-2032) ($MN)
- Table 22 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Secondary Packaging Automation (2024-2032) ($MN)
- Table 23 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Cartoning & Case Packing Systems (2024-2032) ($MN)
- Table 24 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bundling, Wrapping, & Shrink Packaging (2024-2032) ($MN)
- Table 25 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Serialization & Aggregation Systems (2024-2032) ($MN)
- Table 26 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Palletizing, Depalletizing, & Labeling Robots (2024-2032) ($MN)
- Table 27 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Tertiary Packaging Automation (2024-2032) ($MN)
- Table 28 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Automated Guided Vehicles (AGVs) for Warehouse Handling (2024-2032) ($MN)
- Table 29 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Bulk Handling and Shipping Container Systems (2024-2032) ($MN)
- Table 30 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Technology (2024-2032) ($MN)
- Table 31 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Robotics & Pick-and-Place Systems (2024-2032) ($MN)
- Table 32 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Vision Inspection Systems (2024-2032) ($MN)
- Table 33 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Labeling & Serialization Systems (2024-2032) ($MN)
- Table 34 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Conveyors & Automated Material Handling (2024-2032) ($MN)
- Table 35 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Blow-Fill-Seal (BFS) Technology (2024-2032) ($MN)
- Table 36 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Form-Fill-Seal (FFS) Systems (2024-2032) ($MN)
- Table 37 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Application (2024-2032) ($MN)
- Table 38 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
- Table 39 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Clinical Trial Material Manufacturing (2024-2032) ($MN)
- Table 40 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Commercial Production &Processing (2024-2032) ($MN)
- Table 41 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2024-2032) ($MN)
- Table 42 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Formulation and Compounding (2024-2032) ($MN)
- Table 43 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Quality Control & Regulatory Compliance (2024-2032) ($MN)
- Table 44 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Logistics & Inventory Management (2024-2032) ($MN)
- Table 45 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By End User (2024-2032) ($MN)
- Table 46 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Pharmaceutical Manufacturing Companies (2024-2032) ($MN)
- Table 47 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
- Table 48 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs/CMOs) (2024-2032) ($MN)
- Table 49 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Research and Academic Institutions (2024-2032) ($MN)
- Table 50 Global Automation in Solid and Liquid Dosage Pharmaceutical Manufacturing Market Outlook, By Packaging & Equipment Manufacturers (2024-2032) ($MN)
- Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
